{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:58:45Z","timestamp":1793134725169,"version":"4.5.0"},"reference-count":15,"publisher":"Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn J Infect Dis"],"published-print":{"date-parts":[[2020,11,30]]},"DOI":"10.7883\/yoken.jjid.2019.416","type":"journal-article","created":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T22:06:47Z","timestamp":1593468407000},"page":"476-480","source":"Crossref","is-referenced-by-count":9,"title":["Prevalence of High-Level Aminoglycoside Resistance and Genes Encoding Aminoglycoside-Modifying Enzymes in &lt;i&gt;Enterococcus faecalis&lt;\/i&gt; and &lt;i&gt;Enterococcus faecium&lt;\/i&gt; Isolated in a University Hospital in Tokyo"],"prefix":"10.7883","volume":"73","author":[{"given":"Sohei","family":"Harada","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Fujita Health University School of Medicine, Japan"},{"name":"Department of Microbiology and Infectious Diseases, Toho University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Shibue","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Yokohama City Minato Red Cross Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kotaro","family":"Aoki","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Infectious Diseases, Toho University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikazu","family":"Ishii","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Infectious Diseases, Toho University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Tateda","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Infectious Diseases, Toho University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4631","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Garc\u00eda-Solache M, Rice LB. The enterococcus: a model of adaptability to its environment. Clin Microbiol Rev. 2019;32:e00058-18.","DOI":"10.1128\/CMR.00058-18"},{"key":"2","unstructured":"2. Clinical and Laboratory Standards Institute(CLSI). Performance standards for antimicrobial susceptibility testing; 28th informational supplement. Document M100-S28. Wayne, PA: CLSI;2018."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: A scientific statement for healthcare professionals from the American Heart Association. Circulation. 2015;132:1435-86.","DOI":"10.1161\/CIR.0000000000000296"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC Guidelines for the management of infective endocarditis: The task force for the management of infective endocarditis of the European Society of Cardiology (ESC). endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36:3075-128.","DOI":"10.1093\/eurheartj\/ehv319"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Watanabe S, Kobayashi N, Qui\u00f1ones D, et al. Genetic diversity of enterococci harboring the high-level gentamicin resistance gene <i>aac(6&apos;)-Ie-aph(2&apos;&apos;)-Ia<\/i> or <i>aph(2&apos;&apos;)-Ie<\/i> in a Japanese hospital. Microb Drug Resist. 2009;15:185-94.","DOI":"10.1089\/mdr.2009.0917"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Araoka H, Kimura M, Yoneyama A. A surveillance of high-level gentamicin-resistant enterococcal bacteremia. J Infect Chemother. 2011;17:433-4.","DOI":"10.1007\/s10156-010-0175-0"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Osuka H, Nakajima J, Oishi T, et al. High-level aminoglycoside resistance in <i>Enterococcus faecalis<\/i> and <i>Enterococcus faecium<\/i> causing invasive infection: Twelve-year surveillance in the Minami Ibaraki Area. J Infect Chemother. 2016;22:61-3.","DOI":"10.1016\/j.jiac.2015.09.003"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Murdoch DR, Mirrett S, Harrell LJ, et al. Comparison of microscan broth microdilution, synergy quad plate agar dilution, and disk diffusion screening methods for detection of high-level aminoglycoside resistance in enterococcus species. J Clin Microbiol. 2003;41:2703-5.","DOI":"10.1128\/JCM.41.6.2703-2705.2003"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Harada S, Aoki K, Yamamoto S, et al. Clinical and molecular characteristics of <i>Klebsiella pneumoniae<\/i> isolates causing bloodstream infections in Japan: Occurrence of hypervirulent infections in health care. J Clin Microbiol. 2019;57:e01206-19.","DOI":"10.1128\/JCM.01206-19"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. GERACI JE, MARTIN WJ. Antibiotic therapy of bacterial endocarditis. VI. Subacute enterococcal endocarditis; clinical, pathologic and therapeutic consideration of 33 cases. Circulation. 1954;10:173-94.","DOI":"10.1161\/01.CIR.10.2.173"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Gavald\u00e0 J, Len O, Mir\u00f3 JM, et al. Brief communication: treatment of <i>Enterococcus faecalis<\/i> endocarditis with ampicillin plus ceftriaxone. Ann Intern Med. 2007;146:574-9.","DOI":"10.7326\/0003-4819-146-8-200704170-00008"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Fern\u00e1ndez-Hidalgo N, Almirante B, Gavald\u00e0 J, et al. Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating <i>Enterococcus faecalis<\/i> infective endocarditis. Clin Infect Dis. 2013;56:1261-8.","DOI":"10.1093\/cid\/cit052"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Lorenzo MP, Kidd JM, Jenkins SG, et al. In vitro activity of ampicillin and ceftriaxone against ampicillin-susceptible <i>Enterococcus faecium<\/i>. J Antimicrob Chemother. 2019;74:2269-73.","DOI":"10.1093\/jac\/dkz173"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Zhang JM, Wang Q, Han TY, et al. Structure analysis of transposons carrying the aac(6\u2019)-aph(2\u2019\u2019) gene in <i>Enterococcus faecalis<\/i> isolated in Beijing, China, and comparison of their transfer efficiency. Int J Antimicrob Agents. 2018;52:799-804.","DOI":"10.1016\/j.ijantimicag.2018.08.025"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Raven KE, Reuter S, Gouliouris T, et al. Genome-based characterization of hospital-adapted <i>Enterococcus faecalis<\/i> lineages. Nat Microbiol. 2016;1:15033.","DOI":"10.1038\/nmicrobiol.2015.33"}],"container-title":["Japanese Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/73\/6\/73_JJID.2019.416\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T03:40:57Z","timestamp":1606534857000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/73\/6\/73_JJID.2019.416\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,30]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.7883\/yoken.jjid.2019.416","relation":{},"ISSN":["1344-6304","1884-2836"],"issn-type":[{"value":"1344-6304","type":"print"},{"value":"1884-2836","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,30]]}}}